Contrary to popular belief across college campuses, attention deficit hyperactivity disorder (ADHD) medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by ...
Jul 19, 2018
0
1
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.
Jul 17, 2018
0
283
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week by researchers at the University of Pennsylvania and Syracuse University. By modifying the key ingredient in current ...
Jul 17, 2018
0
0
Adopting new guidelines for high blood pressure (hypertension) would dramatically increase the number of people labeled as having the condition and being recommended for drug treatment, finds a study published by The BMJ ...
Jul 11, 2018
0
4
(HealthDay)—High blood pressure is one of the biggest risk factors for heart disease and stroke, yet has no symptoms of its own. That's why having your blood pressure checked regularly is a must, as is controlling it if ...
Jun 20, 2018
0
2
A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients, according to the findings of a multi-center trial led by researchers in the Abramson ...
May 29, 2018
0
2
(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.
May 15, 2018
0
2
(HealthDay)—The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.
May 14, 2018
0
1
(HealthDay)—Production issues have made EpiPens hard to find in some areas of the United States, the U.S. Food and Drug Administration announced Wednesday.
May 9, 2018
0
26
Several herbal remedies have been studied as a treatment for anxiety, but more research is needed to understand the risks and benefits. Here's what we know—and don't know:
Apr 26, 2018
0
13
